Background: The purpose of this study was to determine the frequency of clinical and laboratory findings in children with idiopathic thrombocytopenic purpura (ITP) and to compare the treatment response between corticosteroid and intravenous immunoglobulin.
Methods: From treatment records of patients with diagnosis of ITP, 100 cases were selected. Response to treatment and some other demographic, clinical and laboratory findings were analyzed. Subjects were divided into four groups with three different treatment protocols comprising corticosteroid, intravenous immunoglobulin (IVIG), a combination of both and a group with no drug therapy. Response to treatment was assessed based on thrombocytecount.
Findings: Corticosteroid agents were prescribed for 41% of the patients while IVIG was used in 35% and the combination therapy in 6%. However, 18% received no drug therapy and were observed conservatively. A statistically significant association was found between the age of subjects and the treatment protocol in a way that younger patients received IVIG more than receiving corticosteroid agents. Totally, good response was reported in 58% of the patients, 25% showed average response and 17% did not respond to treatment at all. A statistically significant correlation was observed between the treatment protocol and the response to treatment, in a way that IVIG alone was reported to increase the platelet count more than that of other methods.
Conclusion: IVIG was reported to augment the platelet count more effectively compared to corticosteroids. However, considering the limitations of IVIG prescription, corticosteroids were usually the first-line treatment choice.